Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNP and Sildenafil in CHF with Renal Dysfunction
NCT00972569Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2009
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of nesiritide in heart failure (HF), chronic kidney disease (CKD), sponsored by Mayo Clinic. Started Oct 2009; status: completed.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00972569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972569.